Long-term outcome after benzodiazepine withdrawal treatment in subjects with complicated dependence

Drug and Alcohol Dependence

Volumn 70, Issue 3, 2003, Pages 309-314

  Vorma, Helena ^a,b   Naukkarinen, Hannu ^c   Sarna, Seppo ^d   Kuoppasalmi, Kimmo ^b,d  

^a A klinikkasaatio Finland   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Benzodiazepine; Dependence; Discontinuation; Long term outcome; Predictors

Indexed keywords

BENZODIAZEPINE; DIAZEPAM;

ADDICTION; ADULT; ARTICLE; BEHAVIOR THERAPY; BLOOD SAMPLING; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; TREATMENT OUTCOME; URINALYSIS;

EID: 0038664323     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(03)00014-0     Document Type: Article

References (29)

1. Allgulander C., Borg S., Vikander B. A 4-6 year follow-up of 50 patients with primary dependence on sedative and hypnotic drugs. Am. J. Psychiatry. 141:1984;1580-1582.
2. Benzodiazepine Dependence, Toxicity and Abuse. 1990;APA Press, Washington.
3. Ashton H. Benzodiazepine withdrawal: outcome in 50 patients. Br. J. Addict. 82:1987;665-671.
4. Bishop Y.M.M., Fienberg S.E., Holland P.W. Discrete Multivariate Analysis. Theory and Practice. 1980;The MIT Press, Massachusetts.
5. Busto U.E., Romach M.K., Sellers E.M. Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence. J. Clin. Psychopharmacol. 16:1996;51-57.
6. Busto U., Simpkins J., Sellers E.M., Sisson B., Segal R. Objective determination of benzodiazepine use and abuse in alcoholics. Br. J. Addict. 78:1983;429-435.
7. Bruce T.J., Spiegel D.A., Hegel M.T. Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: a long-term follow-up of the Peoria and Dartmouth studies. J. Consult. Clin. Psychol. 67:1999;151-156.
8. Derogatis L.R., Lipman R.S., Covi L. SCL-90: an outpatient psychiatric rating scale - preliminary report. Psychopharmacology. 9:1973;13-28.
9. Hawley C.J., Tattersall M., Delleportas C., Hallstrom C. Comparison of long-term benzodiazepine users in three settings. Br. J. Psychiatry. 165:1994;792-796.
10. Holton A., Riley P., Tyrer P. Factors predicting long-term outcome after chronic benzodiazepine therapy. J. Affect. Disord. 24:1992;245-252.
11. Holton A., Tyrer P. Five year outcome in patients withdrawn from long-term treatment with diazepam. BMJ. 300:1990;1241-1242.
12. Lillsunde P., Korte T. Comprehensive drug screening in urine using solid-phase extraction and combined TLC and GC/MS identification. J. Anal. Toxicol. 15:1991;71-81.
13. Lillsunde P., Seppälä T. Simultaneous screening and quantitative analysis of benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection. J. Chromatogr. 533:1990;97-110.
14. Malcolm R., Brady K.T., Johnston A.L., Cunningham M. Types of benzodiazepines abused by chemically dependent inpatients. J. Psychoactive Drugs. 25:1993;315-319.
15. Martínez-Cano H., de Iceta Ibánez de Gauna M., Vela-Bueno A., Wittchen H.U. DSM-III-R co-morbidity in benzodiazepine dependence. Addiction. 94:1999;97-107.
16. Morgenstern J., Blanchard K.A., Morgan T.J., Labouvie E., Hayaki J. Testing the effectiveness of cognitive-behavioral treatment for substance abuse in a community setting: within treatment and posttreatment findings. J. Consult. Clin. Psychol. 69:2001;1007-1017.
17. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA. 264:1990;2511-2518.
18. Revicki D.A., Turner R.R., Martindale J.J. Reliability and validity of a health-related quality of life-battery for evaluating outpatient antidepressant treatment. Qual. Life Res. 1:1992;257-266.
19. Rickels K., Case W.G., Schweizer E., Garcia-Espana F., Fridman R. Long-term benzodiazepine users 3 years after participation in a discontinuation program. Am. J. Psychiatry. 148:1991;757-761.
20. Rickels K., DeMartinis N., García-España F., Greenblatt D.J., Mandos L.A., Rynn M. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy. Am. J. Psychiatry. 157:2000;1973-1979.
21. Rickels K., Schweizer E., Weiss S., Zavodnick S. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. Arch. Gen. Psychiatry. 50:1993;61-68.
22. Ross H.E. Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction. 88:1993;209-218.
23. Sanchez-Craig M., Cappell H., Busto U., Kay G. Cognitive-behavioural treatment for benzodiazepine dependence: a comparison of gradual versus abrupt cessation of drug intake. Br. J. Addict. 82:1987;1317-1327.
24. Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. II. Addiction. 88:1993;791-804.
25. Spitzer R.L., Williams J.B.W. Structured Clinical Interview for DSM-III-R, Patient Version. 1985;Biometric Research Department, New York State Psychiatric Institute, New York.
26. Spitzer R.L., Williams J.B.W., Gibbon M. Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). 1990;American Psychiatric Association, Washington, DC.
27. Streiner D.L., Norman G.R. Health Measurement Scales. A Practical Guide to Their Development and Use. 1989;Oxford University Press, Oxford.
28. Vorma A.H., Naukkarinen H.H., Sarna S.J., Kuoppasalmi K.I. Treatment of outpatients with complicated benzodiazepine dependence: comparison of two approaches. Addiction. 97:2002;851-860.
29. Woods J.H., Katz J.L., Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacol. Rev. 44:1992;151-347.